Blood clotting changes during complex aneurysm repair
Part of Blood & lymphatic, Heart & circulation clinical trials.
This study looks at how blood clotting factors change during a complex aneurysm repair. It may help doctors better understand and manage bleeding risks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled to have surgery for a thoraco-abdominal aortic aneurysm (a bulge in the main artery in your chest and belly).
- You have not had any surgery in the last 3 months.
- Your general health is good enough that you are classified as ASA score 3 or less (meaning no severe, life-threatening illness).
- You do not have a known blood clotting disorder (thrombophilia) or a problem with platelet function.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how blood cells change during heart surgery and whether these changes affect bleeding or inflammation after the operation. It may help doctors predict and manage complications in people having heart surgery.
This trial compares two different surgical approaches to repair a life-threatening tear or bulge in the large artery that carries blood from the heart (aorta). The study will help doctors determine which technique is safer and works better for patients needing this complex surgery.
This study follows people with complex aortic aneurysms who need open surgery instead of a less invasive procedure. It aims to understand treatment results and may help improve care for similar patients.
This study looks at what causes blood clots to form inside the aorta after certain types of aortic surgery (called FET and TEVAR). It will help doctors understand why some patients get these clots and how they affect recovery.
This study looks at how well platelets work during heart surgery using a special test called thromboelastography. It may help doctors understand and manage bleeding risks in people having planned heart surgery with a heart-lung machine.
This trial tests whether using a blood thinner in people with new, temporary atrial fibrillation after CABG (heart bypass surgery) can reduce harmful outcomes compared with standard treatment. It may help prevent stroke or other complications if your rhythm problem fits the trial’s timing and risk profile.
Hear when a new Platelet Activation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.